Skip to main content
. Author manuscript; available in PMC: 2017 Mar 4.
Published in final edited form as: Circ Res. 2016 Mar 4;118(5):898–906. doi: 10.1161/CIRCRESAHA.115.306569

Table.

Mitochondrial Respiratory Inhibitors That Have Been Shown to Protect the Heart or Brain From Ischemia/Reperfusion Injury, and Their Sites of Action

Site of Action Inhibitor References
Complex I Rotenone Lesnefsky et al31
Amobarbital Stewart et al53
S-nitrosothiols Nadtochiy et al,54 Prime et al,55 Burwell et al,56 and Nadtochiy et al57
Nitrite Shiva et al58 and Dezfulian et al59
Metformin Owen et al,60 Legtenberg et al,61 Bhamra et al,62 and Matsuzaki et al63
Capsaicin D’Alonzo et al64 and Satoh et al65
Isoflurane Hanley et al66 and Cope et al67
Ranolazine Wyatt et al68
Complex II Atpenin A5 Wojtovich et al69
Diazoxide Anastacio et al70 and Wang et al71
Malonate Chouchani et al,14 Boylston et al,72 and Wojtovich et al73
Nitroxyl Pagliaro et al74 and Shiva et al75
3-Nitropropionate Riepe et al76
Nitro-alkenes Nadtochiy et al77
Complex III Antimycin A Kabir et al78
Complex IV Nitric oxide Zhao et al79
Carbon monoxide Clark et al80
Hydrogen sulfide Khan et al,81 Pan et al,82 and Elrod et al83

Note: Some references are paired such that the phenomenon of a molecule inhibiting a respiratory complex and the phenomenon of it being protective in ischemia/reperfusion injury are not necessarily co-observed in the same experimental system. Inclusion of a molecule in this table should not be misconstrued as claiming that the mechanism of its protection is dependent on its effects on a given respiratory complex.